ClinicalTrials.Veeva

Menu

Influence of an Innovative Telemetric Smartphone Application on Re-hospitalization (TRACE-AF)

U

Universitätsklinikum Hamburg-Eppendorf

Status

Unknown

Conditions

Paroxysmal Atrial Fibrillation

Treatments

Other: Conventional follow up
Device: Telemetric smartphone application

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

A randomized, open, mono-centric pilot study to investigate the influence of an innovative telemetric smartphone application on re-hospitalization and quality of life after cryoballoon pulmonary vein isolation in patients with paroxysmal atrial fibrillation.

Full description

The telemetric smartphone application includes a digitized medical record, a mobile ECG device and a 24-hour on call service by a cardiologist. The hypothesis is that the use of a telemetric smartphone application can reduce re-hospitalization in patients after cryoballoon pulmonary vein isolation. Secondary endpoints are quality of life measurements, health care cost calculations and recurrences of atrial fibrillation after ablation. All patients will undergo ablation and will be randomized into two groups: 1) conventional follow up with outpatient visits 6 and 12 months after ablation compared to 2) a structured follow up with the smartphone application, a mobile ECG device (patients will be able to send in as many ECGs as wanted), up to three phone calls with a cardiologist (24-hour on call service) as well as outpatient visits 6 and 12 months after cryo-ablation.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age > 18 years
  • Written informed consent
  • symptomatic paroxysmal atrial fibrillation (at least two episodes within 3 months prior to ablation)
  • cryoballoon pulmonary vein isolation
  • possession of a compatible smartphone

Exclusion criteria

  • Age < 18 years
  • persistent or permanent atrial fibrillation (AF)
  • prior catheter or surgical ablation of AF
  • pregnant females
  • contraindication for oral anticoagulation
  • manifest hyper-/hypothyroidism
  • no intention to cooperate
  • alcoholism

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Sequential Assignment

Masking

None (Open label)

100 participants in 2 patient groups

Conventional follow up
Other group
Description:
Conventional follow up at physician practice
Treatment:
Other: Conventional follow up
Telemetric smartphone application
Experimental group
Description:
Structured follow up with a telemetric smartphone application
Treatment:
Device: Telemetric smartphone application

Trial contacts and locations

2

Loading...

Central trial contact

Christian Meyer, MD; Melanie Gunawardene, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems